51 completed, 10 terminated, 9 unknown, 7 withdrawn. 88 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 88 | Completed 51, Terminated 10, Unknown 9, Withdrawn 7, Recruiting 6, Not yet recruiting 4, Active not recruiting 1 |
Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children Urgent PC - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | Chi Dang Hornik | 50 | 2027-04-01 | 2026-06-17 |
| Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI) | Phase 4 | Not yet recruiting | University of California, Los Angeles | 120 | 2026-11-01 | 2026-09-15 |
| Prophylactic Antibiotics for Outpatient Urethral Bulking Bactrim (800/160 mg), Keflex (500 mg), Cipro (250 mg), or Macrobid (100mg) - Urinary Tract Infections, Stress Urinary Incontinence | Phase 4 | Recruiting | University of Miami | 150 | 2026-08-19 | 2026-10-29 |
| A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Pro-Nox Nitrous Oxide/Oxygen Delivery System, Standard Care for Bladder Botox Injection, Sham Mask - Overactive Bladder, Neurogenic Bladder | Phase 4 | Not yet recruiting | TriHealth Inc. | 96 | 2026-02-01 | 2026-02-04 |
| Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women Low intensity shockwave therapy, Oral Solifenacin succinate 5 mg - Overactive Bladder (OAB), Urge Incontinence | Phase 4 | Recruiting | Mansoura University | 70 | 2025-11-11 | 2026-03-16 |
| Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) Bactrim or Macrobid, Placebo - Stress Urinary Incontinence | Phase 4 | Recruiting | Ohio State University | 138 | 2025-09-15 | 2026-10-13 |
| Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study Tadalafil 5 mg, Solifenacin 5mg - Overactive Bladder (OAB), Overactive Bladder Syndrome | Phase 4 | Recruiting | Mansoura University | 480 | 2025-09-01 | 2026-02-18 |
| Prophylactic Analgesia for Bladder Botox Injections Phenazopyridine, 1% lidocaine with sodium bicarbonate - Urinary Incontinence, Urinary Incontinence, Urge | Phase 4 | Withdrawn | Montefiore Medical Center | 2025-07-01 | 2025-07-18 | |
| Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections Lidocaine 2% without vessel constrictor - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | University of Louisville | 36 | 2024-12-01 | 2024-11-19 |
| Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry) Solifenacin, Mirabegron, Solifenacin + Mirabegron - Urinary Incontinence in Children | Phase 4 | Active not recruiting | University of Aarhus | 216 | 2024-05-27 | 2026-06-08 |
| Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women vaginal 17 beta-estradiol, Placebo, Behavioral modifications - Lower Urinary Tract Symptoms, Female Genitourinary Disease | Phase 4 | Completed | Mahidol University | 86 | 2024-04-08 | 2025-04-20 |
| Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection Single-Dose Antibiotic, Multi-Dose Antibiotic - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Completed | The Cleveland Clinic | 100 | 2022-12-06 | 2024-01-02 |
| TReating Incontinence for Underlying Mental and Physical Health Tolterodine Tartrate ER, Mirabegron, Placebo - Urinary Incontinence, Urge, Urinary Incontinence | Phase 4 | Recruiting | University of California, San Francisco | 270 | 2022-10-04 | 2026-03-06 |
| Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery Estradiol 0.01% Vag Cream, Placebo vaginal cream - Obstetric; Injury Pelvic Floor, Sexual Dysfunction | Phase 4 | Terminated | University of Alabama at Birmingham | 38 | 2022-07-14 | 2026-02-18 |
| Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial OnabotulinumtoxinA 100 UNT [Botox] - Overactive Bladder, Urinary Urge Incontinence | Phase 4 | Completed | University of California, Irvine | 116 | 2022-05-01 | 2026-02-25 |
| A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder mirabegron - Urge Incontinence, Overactive Bladder (OAB) | Phase 4 | Completed | Astellas Pharma China, Inc. | 249 | 2021-01-06 | 2024-11-15 |
| Sprix for Postoperative Pain Control Following Gynecologic Surgery Sprix - Post Operative Pain Control, Narcotic Use | Phase 4 | Withdrawn | University of Louisville | 2021-01-01 | 2022-07-29 | |
| Minimizing Pain During Office Intradetrussor Botox Injection Bicarbonate protocol, Standard protocol - Overactive Bladder, Overactive Detrusor | Phase 4 | Completed | Boston Urogynecology Associates | 85 | 2020-08-15 | 2025-03-06 |
| Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence Trospium, Placebo oral tablet - Urgency Urinary Incontinence | Phase 4 | Completed | Becky Clarkson | 168 | 2020-02-13 | 2026-04-24 |
| The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling lidocaine with epinephrine, Normal saline with epinephrine - Stress Urinary Incontinence | Phase 4 | Completed | West Penn Allegheny Health System | 150 | 2019-11-25 | 2026-04-30 |
Showing 20 of 88. Sign in to see all of them.
Urinary Bladder, Overactive (35) · Urinary Incontinence, Stress (30) · Urinary Incontinence, Urge (28) · Pelvic Organ Prolapse (5) · Cystocele (4) · Nocturia (4) · Urinary Bladder, Neurogenic (4) · Parkinson Disease (3) · Urinary Tract Infections (3) · Uterine Prolapse (3) · Agnosia (2) · Lower Urinary Tract Symptoms (2) · Pain (2) · Pelvic Floor Disorders (2)
Female Urogenital Diseases and Pregnancy Complications (88) · Male Urogenital Diseases (88) · Pathological Conditions, Signs and Symptoms (88) · Signs and Symptoms (88) · Urination Disorders (88) · Urogenital Diseases (88) · Urological Manifestations (88) · Female Urogenital Diseases (87) · Urologic Diseases (87) · Lower Urinary Tract Symptoms (86) · Urinary Bladder Diseases (39) · Nervous System Diseases (10) · Neurologic Manifestations (10) · Pathological Conditions, Anatomical (7)
Solifenacin Succinate (14) · Tolterodine Tartrate (12) · Botulinum Toxins, Type A (7) · Lidocaine (6) · mirabegron (6) · Nitrofurantoin (3) · fesoterodine (3) · Duloxetine Hydrochloride (2) · Estradiol (2) · Nitrous Oxide (2) · Phenazopyridine (2) · Saline Solution (2) · Tamsulosin (2) · Trimethoprim, Sulfamethoxazole Drug Combination (2) · trospium chloride (2)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (5) · University Magna Graecia (5) · Astellas Pharma Inc (3) · Carelon Research (3) · University of California, San Francisco (3) · University of South Florida (3) · Allergan (2) · Baylor Research Institute (2) · Boston Urogynecology Associates (2) · Brigham and Women's Hospital (2) · Eli Lilly and Company (2) · Mansoura University (2) · TriHealth Inc. (2) · University of Louisville (2) · Astellas Pharma China, Inc. (1)
United States (55) · Italy (7) · Spain (6) · Canada (4) · France (4) · Germany (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Denmark (2) · Egypt (2) · Israel (2) · Netherlands (2) · South Korea (2) · Sweden (2)
Fulvio Zullo, MD (5) · Stefano Palomba, MD (5) · Ann Gormley, MD (2) · A Lenore Ackeman, MD, PhD (1) · Ahmed A Shokeir, professor of urology (1) · Alison Huang, MD, MAS, MPhil (1) · Amin Boroujerdi (1) · Ann Gormley, M.D. (1)
PMID 37160401, PMID 37888839, PMID 37811598, PMID 17105794, PMID 17132474, PMID 17187655, PMID 17983434, PMID 18378748, PMID 18685795, PMID 19032133, PMID 19601704, PMID 19635587, PMID 20018326, PMID 20093904, PMID 20127832, PMID 20479459, PMID 20952014, PMID 22552180, PMID 23208003, PMID 23460503, PMID 23611930, PMID 23635737, PMID 23895188, PMID 24007540, PMID 24148568, PMID 24415559, PMID 24643378, PMID 24737301, PMID 24772006, PMID 25327775, PMID 25800900, PMID 26017787, PMID 29215517, PMID 29324595, PMID 32183741, PMID 32378735, PMID 32725584, PMID 33208652, PMID 33278293, PMID 33955921, PMID 35349162, PMID 35543540, PMID 35580634, PMID 37085880, PMID 38527605, PMID 40025238, PMID 40633093
2017 (1), R01AG064251 (1), R01AG075471 (1)